Supplier News

Redbiotec and GE Healthcare Life Sciences develop a novel manufacturing process for virus-like particles.

SGS to add testing laboratories for biotechnology, extractables and leachables, and elemental impurities to Shanghai facility.

CPI invests $34 million to develop a Biologics Factory of the Future due to open in 2017.

MedImmune and Advaxis partner on immuno-oncology combination clinical trial.

Glatt and Innopharma Labs have formed a partnership to provide Glatt's customers access to Innopharma Labs' non-invasive, real-time 3D particle characterizer, Eyecon, which has the ability to generate live particle size and shape information.

Catalent appoints a new country leader and expands facilities.

Hospira acquires assets from Orchid Chemicals & Pharmaceuticals for $218 million.

Biotage has launched a purification technology, Accelerated Chromatographic Isolation (ACI), which converts simple flash purification into a faster and more economical way to isolate pure compounds.

Onyx Scientific has announced plans to invest in continuous flow manufacturing to allow its customers to explore alternatives during product research and development programs.

PolySciTech's new launch, SpinSwiper, has the potential to speed up microparticle production.

Covance MarketPlace is designed to enable partnerships between the company';s emerging biotechnology and established pharmaceutical clients.

Cytovance Biologics completes GMP manufacture of ARMO BioSciences& lead product.

Aesica Pharmaceuticals S.r.I. collaborates with QAD to meet China&s Food and Drug Administration's shortened serialization deadline.

Frontage Labs will expand its CMC facility in Exton, PA.

Rentschler plans to build two stainless-steel bioreactors to target market supply.

Medicenna Therapeutics selects Kalon Biotherapeutics to manufacture a new brain cancer drug for children and adults.

Recipharm and CTC will offer packages for Phase I studies.

SGS introduces the Cobas 6000 Analyzer System for its France-based laboratory.

Jones Packaging introduces a new solid dose vial line in its Toronto facility.

Arecor and the Center for Process Innovation (CPI) Biologics are working on a project to enhance the compatibility of biologics with their containers.

Funding boosts life-sciences manufacturing in West Michigan.

Catalent and AAPS announce the five winners of its annual academic competition.

The fabrication facility will supply modular construction to the US life-science market.

The new mAb manufacturing facility in Switzerland will supply material for clinical development.

Cellectis enters an agreement with CELLforCURE for cGMP clinical manufacturing of allogeneic T-cells.

Xcelience opens a clinical packaging and distribution facility in Birmingham, UK.

APIC provides guidance on cleaning validation in API plants and how to implement GDP for APIs.

Malvern Instruments will acquire the MicroCal business from GE Healthcare Life Sciences.

Alexion initiates a voluntary nationwide recall of certain lots of soliris (eculizumab) concentrated solution for intravenous infusion because of visible particulate matter in a single lot.

AMRI adds commercial-scale sterile injectable manufacturing capabilities with acquisition of Oso Biopharmaceuticals.